0000929638-23-001538.txt : 20230519 0000929638-23-001538.hdr.sgml : 20230519 20230519160216 ACCESSION NUMBER: 0000929638-23-001538 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230518 FILED AS OF DATE: 20230519 DATE AS OF CHANGE: 20230519 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kaplan Myron CENTRAL INDEX KEY: 0001672645 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34673 FILM NUMBER: 23939920 MAIL ADDRESS: STREET 1: C/O KLEINBERG, KAPLAN, WOLFF & COHEN, PC STREET 2: 551 FIFTH AVENUE, 18TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10176 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CorMedix Inc. CENTRAL INDEX KEY: 0001410098 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 CONNELL DRIVE STREET 2: SUITE 4200 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: 908-517-9500 MAIL ADDRESS: STREET 1: 300 CONNELL DRIVE STREET 2: SUITE 4200 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 4 1 form4.xml X0407 4 2023-05-18 0001410098 CorMedix Inc. CRMD 0001672645 Kaplan Myron C/O CORMEDIX INC. 300 CONNELL DRIVE BERKELEY HEIGHTS NJ 07922 true false Common Stock 2023-05-18 4 P 0 6000 4.543 A 166034 D Common Stock 20000 I Spouse Common Stock 10000 I Spouse as Guardian for Grandchildren The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.53 to $4.55, inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. /s/ Myron Kaplan 2023-05-19